Literature DB >> 17650428

[Effects of solution of dry powder of ShenSongYangXin capsule on sodium current and L-type calcium current in ventricular myocytes: experiment with guinea pig].

Ning Li1, You-ping Huo, Ke-juan Ma, Qi Sun, Jie-lin Pu.   

Abstract

OBJECTIVE: To investigate the effects of dry powder of ShenSongYangXin capsule on sodium current (I(Na)) and L-type calcium current (I(Ca, L)) in ventricular myocytes.
METHODS: Ventricular myocytes were isolated from guinea pig. Solution of the dry powder of ShenSongYangXin capsule of the concentrations of 1%, 0.5%, and 0.25% was added into the suspension of the myocytes. Whole cell patch-clamp technique was used to detect the I(Na) and I(Ca, L) in the ventricular myocytes. RESULT: ShenSongYangXin decreased the peak I(Na) from 27.2 +/- 5.4 (pA/pF) to 14.9 +/- 2.8 (pA/pF), with a decrease rate of 44.8% +/- 7.7% (n = 5, P < 0.05). The solution of dry powder of ShenSongYangXin of the concentrations of 1%, 0.5%, and 0.25% decreased the peak L-type calcium channel current (I(ca, L)) significantly in a concentration dependent manner with the reduction rates of 50.7% +/- 5.6%, 44.8% +/- 6.5%, and 19.2% +/- 1.1% respectively (n = 5, all P < 0.05). ShenSongYangXin shifted up both the I approximately 1V curve of I(Na) and that of I(Ca, L), while their active, peak and reverse potentials didn't change.
CONCLUSION: ShenSongYangXin blocks both I(Na) and I(Ca, L), which may contributes to some of its antiarrhythmic effect.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17650428

Source DB:  PubMed          Journal:  Zhonghua Yi Xue Za Zhi        ISSN: 0376-2491


  8 in total

Review 1.  Alternative medicine in atrial fibrillation treatment-Yoga, acupuncture, biofeedback and more.

Authors:  Arun Kanmanthareddy; Madhu Reddy; Gopi Ponnaganti; Hari Priya Sanjani; Sandeep Koripalli; Nivedita Adabala; Avanija Buddam; Pramod Janga; Thanmay Lakkireddy; Sudharani Bommana; Ajay Vallakati; Donita Atkins; Dhanunjaya Lakkireddy
Journal:  J Thorac Dis       Date:  2015-02       Impact factor: 2.895

2.  Qiliqiangxin affects L type ca(2+) current in the normal and hypertrophied rat heart.

Authors:  Yidong Wei; Xiaoyu Liu; Lei Hou; Wenliang Che; Erlinda The; Muktanand Vikash Jhummon
Journal:  Evid Based Complement Alternat Med       Date:  2012-03-26       Impact factor: 2.629

3.  The electrophysiological effects of qiliqiangxin on cardiac ventricular myocytes of rats.

Authors:  Yidong Wei; Xiaoyu Liu; Haidong Wei; Lei Hou; Wenliang Che; Erlinda The; Gang Li; Muktanand Vikash Jhummon; Wanlin Wei
Journal:  Evid Based Complement Alternat Med       Date:  2013-10-22       Impact factor: 2.629

4.  Effect of Shensong Yangxin on the Progression of Paroxysmal Atrial Fibrillation is Correlated with Regulation of Autonomic Nerve Activity.

Authors:  Hong-Yi Zhao; Shu-Di Zhang; Kai Zhang; Xi Wang; Qing-Yan Zhao; Shu-Juan Zhang; Zi-Xuan Dai; Yong-Sheng Qian; You-Jing Zhang; Hao-Tian Wei; Yan-Hong Tang; Cong-Xin Huang
Journal:  Chin Med J (Engl)       Date:  2017-01-20       Impact factor: 2.628

Review 5.  Application of Traditional Chinese Medicine in Treatment of Atrial Fibrillation.

Authors:  Yan Dong; Jiangquan Liao; Kuiwu Yao; Wenrui Jiang; Jie Wang
Journal:  Evid Based Complement Alternat Med       Date:  2017-01-24       Impact factor: 2.629

Review 6.  The Role of Biologically Active Ingredients from Natural Drug Treatments for Arrhythmias in Different Mechanisms.

Authors:  Jie Li; Dan Hu; Xiaoli Song; Tao Han; Yonghong Gao; Yanwei Xing
Journal:  Biomed Res Int       Date:  2017-04-11       Impact factor: 3.411

7.  Chinese medicine shensongyangxin is effective for patients with bradycardia: results of a randomized, double-blind, placebo-controlled multicenter trial.

Authors:  Yunfang Liu; Ning Li; Zhenhua Jia; Feng Lu; Jielin Pu
Journal:  Evid Based Complement Alternat Med       Date:  2014-01-16       Impact factor: 2.629

8.  Shensong Yangxin capsule reduces atrial fibrillation susceptibility by inhibiting atrial fibrosis in rats with post-myocardial infarction heart failure.

Authors:  Jin Ma; Chunxia Yin; Shiyu Ma; Huiliang Qiu; Chaoyang Zheng; Qiuxiong Chen; Chunhua Ding; Weihui Lv
Journal:  Drug Des Devel Ther       Date:  2018-10-10       Impact factor: 4.162

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.